P2B001 (low dose combination of extended-release pramipexole and rasagiline) versus titrated extended-release pramipexole in the management of early Parkinson's disease: Exploratory findings from a randomized, controlled trial

被引：0
|
作者：
Elmer, Lawrence [1 ]
Litman, Pninit [2 ]
Friedman, Hadas [2 ]
Fitzer-Attas, Cheryl [2 ]
Oren, Sheila [2 ]
机构：
[1] Univ Toledo, Coll Med & Life Sci, Dept Neurol, Toledo, OH USA
[2] Pharma Two B, Rehovot, Israel
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203489
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S32.010
引用
收藏
页数：4
相关论文
共 41 条
  • [1] Safety and Efficacy of P2B001 (Low Dose Combination of Extended-release Pramipexole and Rasagiline) in Patients with Early Parkinson's Disease: Subgroup Analyses from a Randomized, Controlled
    Falconer, D.
    Litman, P.
    Friedman, H.
    Oren, S.
    Fitter-Attas, C.
    MOVEMENT DISORDERS, 2023, 38 : S21 - S21
  • [2] A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease
    Olanow, C. Warren
    Hauser, Robert A.
    Burdick, Daniel J.
    Dhall, Rohit
    de Marcaida, Joy Antonelle
    Gil, Ramon A.
    Kreitzman, David L.
    Elmer, Lawrence W.
    Mcgarry, Andrew
    Kieburtz, Karl
    MOVEMENT DISORDERS, 2024, 39 (02) : 350 - 359
  • [3] Extended-release pramipexole in advanced Parkinson disease A randomized controlled trial
    Schapira, A. H. V.
    Barone, P.
    Hauser, R. A.
    Mizuno, Y.
    Rascol, O.
    Busse, M.
    Salin, L.
    Juhel, N.
    Poewe, W.
    NEUROLOGY, 2011, 77 (08) : 767 - 774
  • [4] A Randomized Trial of a Low-Dose Rasagiline and Pramipexole Combination (P2B001) in Early Parkinson's Disease
    Olanow, C. Warren
    Kieburtz, Karl
    Leinonen, Mika
    Elmer, Lawrence
    Giladi, Nir
    Hauser, Robert A.
    Klepiskaya, Olga S.
    Kreitzman, David L.
    Lew, Mark F.
    Russell, David S.
    Kadosh, Shaul
    Litman, Pninit
    Friedman, Hadas
    Linvah, Nurit
    MOVEMENT DISORDERS, 2017, 32 (05) : 783 - 789
  • [5] Pramipexole extended-release is effective in early Parkinson's disease
    Poewe, W.
    Barone, P.
    Hauser, R. A.
    Mizuno, Y.
    Rascol, O.
    Schapira, A.
    Haaksma, M.
    Juhel, N.
    MOVEMENT DISORDERS, 2009, 24 : S273 - S273
  • [6] Extended-release pramipexole in early Parkinson disease A 33-week randomized controlled trial
    Poewe, W.
    Rascol, O.
    Barone, P.
    Hauser, R. A.
    Mizuno, Y.
    Haaksma, M.
    Salin, L.
    Juhel, N.
    Schapira, A. H. V.
    NEUROLOGY, 2011, 77 (08) : 759 - 766
  • [7] P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson's Disease
    Hauser, Robert A.
    Giladi, Nir
    Poewe, Werner
    Brotchie, Jonathan
    Friedman, Hadas
    Oren, Sheila
    Litman, Pninit
    ADVANCES IN THERAPY, 2022, 39 (05) : 1881 - 1894
  • [8] P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease
    Robert A. Hauser
    Nir Giladi
    Werner Poewe
    Jonathan Brotchie
    Hadas Friedman
    Sheila Oren
    Pninit Litman
    Advances in Therapy, 2022, 39 : 1881 - 1894
  • [9] Patient considerations in early management of Parkinson's disease: focus on extended-release pramipexole
    Salawu, Fatai Kunle
    PATIENT PREFERENCE AND ADHERENCE, 2012, 6 : 49 - 54
  • [10] Slow release fixed dose combination of low doses pramipexole and rasagiline (p2b001) for the treatment of early Parkinson's disease (PD)
    Olanow, C.
    Kieburtz, K.
    Livnah, N.
    MOVEMENT DISORDERS, 2017, 32
12345